Telstra shares were feeling the pressure as its partly paid T3 shares appeared in high demand in an overall subdued share market on Monday.
Southern Cross Equities expects Ansell to grow earnings as the latex price becomes less of an issue, with any downside offset by potential corporate interest.
Newcrest has restructured its hedge book to provide more near term exposure to higher spot gold prices.
Changes to the Pharmaceutical Benefits Scheme designed to lower the cost of generic drugs are expected to have little earnings impact on industry players given offsetting compensation payments to pharmacists.
Westpac suggests the global economy can withstand a slowing in the US economy, as other regions should continue to post near-trend growth.
There is disagreement about what the drought will do to wine prices, but Deutsche Bank has upgraded beleaguered McGuigan Simeon on hopes for 2008.
Vodafone Australia is looking to increase its product offering by acquiring fixed broadband assets in Australia.
ChemGenex has received fast-tracking status from the US FDA for its Leukaemia compound, ABN Amro Morgans suggesting the stock may move higher as a result.
What happens when you conduct a survey about consumer confidence over five days immediately following the announcement of another RBA rate hike? That predictable sinking feeling!
The NSW economy has been Australia’s worst of late and the Commonwealth Bank sees little improvement until the housing sector turns around, likely late next year.